Chapter 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growth in number of geriatric population
3.5.1.2. Increase in prevalence of chronic diseases
3.5.1.3. Rise in demand for diagnostic imaging procedures

3.5.2. Restraints

3.5.2.1. Shortage of supplies of imaging reagents
3.5.2.2. Stringent regulatory approvals
3.5.2.3. Reluctance in adopting nuclear reagents

3.5.3. Opportunities

3.5.3.1. Technological Advancements Leading
3.5.3.2. Development of personalized therapy
3.5.3.3. Untapped Markets in Developing Economies

Chapter 4 MEDICAL IMAGING REAGENTS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CONTRAST REAGENTS

4.2.1. Market size and forecast

4.3. OPTICAL REAGENTS

4.3.1. Market size and forecast

4.4. NUCLEAR REAGENTS

4.4.1. Market size and forecast

Chapter 5 MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NANOPARTICLES

5.2.1. Market size and forecast

5.3. FLUORESCENT DYES & PROBES

5.3.1. Market size and forecast

5.4. RADIOPHARMACEUTICALS

5.4.1. Market size and forecast

5.5. FLUORESCENT PROTEINS

5.5.1. Market size and forecast

5.6. QUANTUM DOTS

5.6.1. Market size and forecast

Chapter 6 MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTICS

6.2.1. Market size and forecast

6.3. DRUG DISCOVERY & DEVELOPMENT

6.3.1. Market size and forecast

6.4. R&D

6.4.1. Market size and forecast

Chapter 7 MEDICAL IMAGING REAGENTS MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. India market size and forecast
7.4.3.2. Japan market size and forecast
7.4.3.3. China market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

Chapter 8 COMPANY PROFILES

8.1. BRACCO IMAGING SPA

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. BAYER HEALTHCARE AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. LANTHEUS MEDICAL IMAGING, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. GE HEALTHCARE

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. SIEMENS HEALTHCARE

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments

8.6. MALLINCKRODT PHARMACEUTICALS

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. THERMO FISHER SCIENTIFIC, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. MERCK

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. BECTON DICKINSON & COMPANY

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. CARDINAL HEALTH, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments